These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 35924579)

  • 1. Mass spectrometry-based proteomics in clinical practice amyloid typing: state-of-the-art from a French nationwide cohort.
    Colombat M; Gaspard M; Camus M; Dalloux-Chioccioli J; Delas A; Poullot E; Moktefi A; François A; Moreau A; Gibier JB; Raynaud P; Huart A; Piedrafita A; Gilhodes J; Lairez O; Grateau G; Georgin-Lavialle S; Maisonneuve H; Moreau P; Jaccard A; Bridoux F; Plante-Bordeneuve V; Damy T; Mal H; Brousset P; Valleix S; Burlet-Schiltz O
    Haematologica; 2022 Dec; 107(12):2983-2987. PubMed ID: 35924579
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical diagnosis and typing of systemic amyloidosis in subcutaneous fat aspirates by mass spectrometry-based proteomics.
    Vrana JA; Theis JD; Dasari S; Mereuta OM; Dispenzieri A; Zeldenrust SR; Gertz MA; Kurtin PJ; Grogg KL; Dogan A
    Haematologica; 2014 Jul; 99(7):1239-47. PubMed ID: 24747948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amyloid Typing by Mass Spectrometry in Clinical Practice: a Comprehensive Review of 16,175 Samples.
    Dasari S; Theis JD; Vrana JA; Rech KL; Dao LN; Howard MT; Dispenzieri A; Gertz MA; Hasadsri L; Highsmith WE; Kurtin PJ; McPhail ED
    Mayo Clin Proc; 2020 Sep; 95(9):1852-1864. PubMed ID: 32861330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteomics in molecular diagnosis: typing of amyloidosis.
    Loo D; Mollee PN; Renaut P; Hill MM
    J Biomed Biotechnol; 2011; 2011():754109. PubMed ID: 22131817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Classification of Amyloidosis by Model-Assisted Mass Spectrometry-Based Proteomics.
    Palstrøm NB; Rojek AM; Møller HEH; Hansen CT; Matthiesen R; Rasmussen LM; Abildgaard N; Beck HC
    Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical characteristics and prognosis of cardiac amyloidosis defined by mass spectrometry-based proteomics in an Australian cohort.
    Withers B; McCaughan G; Hayward C; Kotlyar E; Jabbour A; Rainer S; De Angelis E; Horvath N; Milliken S; Dogan A; MacDonald P; Moore J
    Intern Med J; 2022 Jan; 52(1):69-78. PubMed ID: 32981138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation of histomorphological pattern of cardiac amyloid deposition with amyloid type: a histological and proteomic analysis of 108 cases.
    Larsen BT; Mereuta OM; Dasari S; Fayyaz AU; Theis JD; Vrana JA; Grogan M; Dogan A; Dispenzieri A; Edwards WD; Kurtin PJ; Maleszewski JJ
    Histopathology; 2016 Apr; 68(5):648-56. PubMed ID: 26212778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical Laboratory Test Using Proteomics: The Usefulness of Proteomic Techniques for Amyloid Typing].
    Tasaki M; Obayashi K; Ando Y
    Rinsho Byori; 2015 Aug; 63(8):980-5. PubMed ID: 26638436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Classification of amyloidosis by laser micro-dissection and mass spectrometry based proteomic analysis].
    Shen K; Sun W; Sun J; Sun W; Zhong D; Cao X; Zhou D; Li J
    Zhonghua Xue Ye Xue Za Zhi; 2015 Feb; 36(2):99-102. PubMed ID: 25778882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteomics with Mass Spectrometry Imaging: Beyond Amyloid Typing.
    Lavatelli F; Merlini G
    Proteomics; 2018 Apr; 18(7):e1700353. PubMed ID: 29389069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical typing of amyloid in fixed paraffin-embedded samples by an automatic procedure: Comparison with immunofluorescence data on fresh-frozen tissue.
    Barreca A; Bottasso E; Veneziano F; Giarin M; Nocifora A; Martinetti N; Attanasio A; Biancone L; Benevolo G; Roccatello D; Cassoni P; Papotti MG;
    PLoS One; 2021; 16(8):e0256306. PubMed ID: 34428239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical proteomics for diagnosis and typing of systemic amyloidoses.
    Brambilla F; Lavatelli F; Merlini G; Mauri P
    Proteomics Clin Appl; 2013 Jan; 7(1-2):136-43. PubMed ID: 23184874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mass spectrometry-based proteomic diagnosis of renal immunoglobulin heavy chain amyloidosis.
    Sethi S; Theis JD; Leung N; Dispenzieri A; Nasr SH; Fidler ME; Cornell LD; Gamez JD; Vrana JA; Dogan A
    Clin J Am Soc Nephrol; 2010 Dec; 5(12):2180-7. PubMed ID: 20876678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Proteomics, a new tool for an accurate typing of amyloidosis].
    Colombat M; Holifanjaniaina S; Onifarasoaniaina S; Valleix S; Maisonneuve H; Kahn JE;
    Rev Med Interne; 2015 May; 36(5):346-51. PubMed ID: 25544147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A stepwise data interpretation process for renal amyloidosis typing by LMD-MS.
    Ke M; Li X; Wang L; Yue S; Zhao B
    BMC Nephrol; 2022 Apr; 23(1):144. PubMed ID: 35418036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteomic typing of amyloid deposits in systemic amyloidoses.
    Lavatelli F; Vrana JA
    Amyloid; 2011 Dec; 18(4):177-82. PubMed ID: 22080761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How I treat amyloidosis: the importance of accurate diagnosis and amyloid typing.
    Leung N; Nasr SH; Sethi S
    Blood; 2012 Oct; 120(16):3206-13. PubMed ID: 22948045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and Validation of Mass Spectrometry-Based Targeted Analysis for Amyloid Proteins.
    Park J; Lee GY; Choi JO; Jeon ES; Kim K; Kim JS; Lee SY
    Proteomics Clin Appl; 2018 May; 12(3):e1700106. PubMed ID: 29266842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proteomics and mass spectrometry in the diagnosis of renal amyloidosis.
    Picken MM
    Clin Kidney J; 2015 Dec; 8(6):665-72. PubMed ID: 26613021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Twists and turns of determining amyloid type and amyloid-related organ damage: discordance and clinical skepticism in the era of proteomic typing.
    Kaul E; Pilichowska M; Vullaganti M; Madan N; Comenzo RL
    Amyloid; 2014 Mar; 21(1):62-5. PubMed ID: 24256111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.